Evidence map›Paper›PMID 31680123›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2020

The genomic and clinical landscape of fetal akinesia.

Matthias Pergande, Susanne Motameny, Özkan Özdemir, Mona Kreutzer, Haicui Wang, Hülya-Sevcan Daimagüler, Kerstin Becker, Mert Karakaya, Harald Ehrhardt, Nursel Elcioglu and 21 more

Erratum issuedOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
9.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. A homozygous single-nucleotide variant inJournal of neuromuscular diseases · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. The impact of SETBP1 mutations in neurological diseases and cancer.Genes to cells : devoted to molecular & cellular mechanisms · 2023
    Review
  12. Article
  13. Adenylosuccinic Acid: An Orphan Drug with Untapped Potential.Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  14. Review
  15. Bi-allelic loss-of-function variants inJournal of medical genetics · 2023
    Article
  16. Genetic Mapping of Behavioral Traits Using the Collaborative Cross Resource.International journal of molecular sciences · 2022
    Article
  17. Article
  18. Article
  19. The phenotypic spectrum of PCDH12 associated disorders - Five new cases and review of the literature.European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society · 2022
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 11 institutions in 6 countries.

Matthias PergandeUniversity of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
Susanne MotamenyUniversity of Cologne, Cologne Center for Genomics CCG, Cologne, Germany.
Özkan ÖzdemirUniversity of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
Mona KreutzerUniversity of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
Haicui WangUniversity of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
Hülya-Sevcan DaimagülerUniversity of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
Kerstin BeckerUniversity of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
Mert KarakayaUniversity of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
Harald EhrhardtDepartment of General Pediatrics and Neonatology, Justus-Liebig-University, Gießen, Germany.
Nursel ElciogluDepartment of Pediatric Genetics, Marmara University Medical School, Istanbul, Turkey.
Slavica OstojicDepartment of Neurology, Mother and Child Health Care Institute of Serbia "Dr. Vukan Cupic", Belgrade, Serbia.
Cho-Ming ChaoDepartment of General Pediatrics and Neonatology, Justus-Liebig-University, Gießen, Germany.
Amit KawaliaUniversity of Cologne, Cologne Center for Genomics CCG, Cologne, Germany.
Özgür DumanDepartment of Pediatric Neurology, Akdeniz University Hospital, Antalya, Turkey.
Anne KoyUniversity of Cologne, University Hospital Cologne and Faculty of Medicine, Department of Pediatrics, Cologne, Germany.
Andreas HahnDepartment of Pediatric Neurology, Social Pediatrics and Epileptology, Justus-Liebig-University, Gießen, Germany.
Jens ReimannDepartment of Neurology, Rheinische Friedrich-Wilhelms-University, Bonn, Germany.
Katharina SchonerInstitute of Pathology, Philipps University of Marburg, Marburg, Germany.
Anne SchänzerInstitute of Neuropathology, Justus-Liebig-University, Gießen, Germany.
Jens H WesthoffHeidelberg University, University Children's Hospital Heidelberg, Department of Pediatrics, Heidelberg, Germany.
Eva Maria Christina SchwaiboldInstitute of Human Genetics, Heidelberg University, Institute of Human Genetics, Heidelberg, Germany.
Mireille CosseeUniversity of Montpellier, University Hospital of Montpellier, Molecular Diagnostic Laboratory, Montpellier, France.
Marion Imbert-BouteilleUniversity of Montpellier, University Hospital of Montpellier, Medical Genetics Department, Montpellier, France.
Harald von PeinJohannes-Gutenberg University Mainz, University Medical Center Mainz, Institute of Neuropathology, Mainz, Germany.
Göknur HalilogluHacettepe University, Children's Hospital, Department of Pediatric Neurology, Ankara, Turkey.
Haluk TopalogluHacettepe University, Children's Hospital, Department of Pediatric Neurology, Ankara, Turkey.
Janine AltmüllerUniversity of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
Peter NürnbergUniversity of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
Holger ThieleUniversity of Cologne, Cologne Center for Genomics CCG, Cologne, Germany.
Raoul HellerUniversity of Cologne, University Hospital Cologne, Institute of Human Genetics, Cologne, Germany.
Sebahattin CirakUniversity of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany. sebahattin.cirak@uk-koeln.de.ORCID http://orcid.org/0000-0003-3040-6477
University of Cologne · DEJustus-Liebig-Universität Gießen · DEHacettepe University Hospital · TRHeidelberg University · DEUniversité de Montpellier · FRAkdeniz University Hospital · TREastern Mediterranean University · CYInstitute of Public Health of Serbia · RSJohannes Gutenberg University Mainz · DEPhilipps University of Marburg · DEUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeFetal akinesia has multiple clinical subtypes with over 160 gene associations, but the genetic etiology is not yet completely understood.

methodsIn this study, 51 patients from 47 unrelated families were analyzed using next-generation sequencing (NGS) techniques aiming to decipher the genomic landscape of fetal akinesia (FA).

resultsWe have identified likely pathogenic gene variants in 37 cases and report 41 novel variants. Additionally, we report putative pathogenic variants in eight cases including nine novel variants. Our work identified 14 novel disease-gene associations for fetal akinesia: ADSSL1, ASAH1, ASPM, ATP2B3, EARS2, FBLN1, PRG4, PRICKLE1, ROR2, SETBP1, SCN5A, SCN8A, and ZEB2. Furthermore, a sibling pair harbored a homozygous copy-number variant in TNNT1, an ultrarare congenital myopathy gene that has been linked to arthrogryposis via Gene Ontology analysis.

conclusionOur analysis indicates that genetic defects leading to primary skeletal muscle diseases might have been underdiagnosed, especially pathogenic variants in RYR1. We discuss three novel putative fetal akinesia genes: GCN1, IQSEC3 and RYR3. Of those, IQSEC3, and RYR3 had been proposed as neuromuscular disease-associated genes recently, and our findings endorse them as FA candidate genes. By combining NGS with deep clinical phenotyping, we achieved a 73% success rate of solved cases.

Indexed as

AdolescentAdultArthrogryposisChildChild, PreschoolDNA Copy Number VariationsFemaleFetal DiseasesGenetic Predisposition to DiseaseGuanine Nucleotide Exchange FactorsHigh-Throughput Nucleotide SequencingHumansInfantInfant, NewbornMaleMuscular DiseasesGCN1 protein, humanGuanine Nucleotide Exchange FactorsIQSEC3 protein, humanRNA-Binding ProteinsRyanodine Receptor Calcium Release ChannelRYR3 protein, humanTrans-Activatorsarthrogryposiscopy-number variationexomefetal akinesiamyopathy

Identifiers

PMID31680123
OpenAlexW2983856535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.